Hypertrophic cardiomyopathy (HCM) is the leading identifiable cause of sudden cardiac death in individuals under 35, including competitive athletes. Early diagnosis and management are critical to reducing morbidity and mortality. A multidisciplinary, evidence-based approach, supported by strong communication, ethical decision-making, and patient education—ensures accurate diagnosis, optimized therapy, and improved long-term outcomes for patients with HCM.
This exclusive webinar will feature international experts Professor Andrew Wang and Dr. Anjali T Owens as they discuss real-world case experiences, evolving diagnostic strategies, and the transition from conventional care to targeted therapeutic approaches. Join us on 12th December 2025 , at 8:00 PM IST for an engaging scientific dialogue exploring how precision diagnosis and novel therapies are transforming the management landscape…
